Related Experiment Video
Updated: May 10, 2026

10:13
Cannula Implantation into the Cisterna Magna of Rodents
Published on: May 23, 2018
46.1K
Glymphatic Function as a Prognostic Biomarker in Prolonged Disorders of Consciousness
Dian-Wei Wu1, Chang-Geng Song1, Rong Chen1
1Department of Neurology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
CNS Neuroscience & Therapeutics
|July 24, 2025
Summary
Glymphatic system function is impaired in prolonged disorders of consciousness (pDoC). Impaired glymphatic function, measured by blood-oxygen-level-dependent and cerebrospinal fluid (BOLD-CSF) coupling, can predict improved consciousness outcomes in pDoC patients.
Area of Science:
- Neuroscience
- Neurology
- Biomedical Engineering
Background:
- The glymphatic system is crucial for waste clearance in the central nervous system.
- Prolonged disorders of consciousness (pDoC) represent a significant clinical challenge.
- Understanding the underlying pathophysiology of pDoC is essential for developing prognostic tools.
Purpose of the Study:
- To investigate glymphatic system function in patients with pDoC.
- To evaluate the prognostic value of glymphatic function in pDoC.
- To explore the relationship between glymphatic function and consciousness recovery.
Main Methods:
- Prospective cohort study including 40 pDoC patients and 20 healthy controls.
- Glymphatic function assessed using blood-oxygen-level-dependent and cerebrospinal fluid (BOLD-CSF) couplings, measuring time-lags and strengths.
- Clinical outcome determined 6 months post-enrollment using the Coma Recovery Scale-Revised (CRS-R).
Main Results:
- pDoC patients showed significantly delayed BOLD-CSF coupling time-lags and reduced coupling strengths compared to controls.
- Shorter global BOLD-CSF coupling time-lags predicted improved consciousness at 6 months.
- The prognostic model achieved 85.7% accuracy with an area under the curve of 0.837.
Conclusions:
- Glymphatic system function is impaired in patients with pDoC.
- BOLD-CSF coupling serves as a novel prognostic biomarker for consciousness recovery in pDoC.
- This finding may inform future therapeutic strategies targeting the glymphatic system.

